(+/-)-3-(4-AMINO-1H-PYRROLO[2,3-D]PYRIMIDIN-1-YL)-5-(HYDROXYMETHYL)-(ALPHA,2-ALPHA,3-BETA,5-BETA)-1,2-CYCLOPENTANEDIOL, THE CARBOCYCLIC ANALOG OF TUBERCIDIN

被引：13

|

作者：

SECRIST, JA

CLAYTON, SJ

MONTGOMERY, JA

机构：

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1984年 / 27卷 / 04期

关键词：

D O I：

10.1021/jm00370a018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：534 / 536

页数：3

相关论文

共 50 条

[21] SYNTHESIS OF 5-(HYDROXYHEXAFLUOROPROP-2-YL)-1-(BETA-D-GLUCOPYRANOSYL) AND 3-(HYDROXYHEXAFLUOROPROP-2-YL)-1-(BETA-D-GLUCOPYRANOSYL) INDOLES
CHKANIKOV, ND
ZELENIN, AE
BRONDZ, NL
GALAKHOV, MV
KOLOMIETS, AF
FOKIN, AV
BULLETIN OF THE ACADEMY OF SCIENCES OF THE USSR DIVISION OF CHEMICAL SCIENCE, 1986, 35 (10): : 2093 - 2098
[22] 2-ALPHA, 3-ALPHA-EPITHIO-5-ALPHA-ANDROSTAN-17-BETA-YL 1-METHOXYCYCLOPENTYL ETHER IN TREATMENT OF ADVANCED BREAST-CANCER
不详
CANCER, 1978, 41 (02) : 758 - 760
[23] C-NUCLEOSIDES AND RELATED COMPOUNDS .8. SYNTHESIS OF 5-(4'BETA-HYDROXYMETHYL-2'BETA,3'ALPHA-DIHYDROXYCYCLOPENT-1'BETA-YL)-6-AZAURACIL
JUST, G
OUELLET, R
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1976, 54 (18): : 2925 - 2934
[24] 5-BETA,7-ALPHA-ALPHA-DIMETHYL-2,3,3-ALPHA-ALPHA,4,5,6,7,7-ALPHA-OCTAHYDRO-1-OXO-1H-INDENE-5-ALPHA-ACETIC ACID, C13H20O3 (I) AND [2-ALPHA,3'-ALPHA-BETA,7'-ALPHA-BETA]-DECAYHDRO-7'-ALPHA-METHYL-SPIRO[FURAN-3(2H),5'-[2H]INDAN]-5,1'-DIONE, C13H18O3 (II) - A COMPARISON OF EXPERIMENTAL AND FORCE-FIELD CALCULATED GEOMETRIES
BERTOLASI, V
FERRETTI, V
GILLI, G
CRYSTAL STRUCTURE COMMUNICATIONS, 1982, 11 (04): : 1459 - 1465
[25] SYNTHESIS OF 4-HYDROXY-2H-NAPHTHO[1',2'-4,5]THIAZOLO[3,2-ALPHA]-PYRIMIDIN-2-ONE
LIU, KC
SHIH, BJ
ARCHIV DER PHARMAZIE, 1985, 318 (12) : 1138 - 1140
[26] 2-(3-{(3R, 4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-piperidin-1-yl}oxetan-3-yl)acetonitrile monohydrate
Gehringer, Matthias
Pfaffenrot, Ellen
Keck, Peter R. W. E. F.
Schollmeyer, Dieter
Laufer, Stefan A.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O382 - +
[27] SYNTHESIS OF (5,6)-EPOXY-(1-ALPHA, 2-BETA, 3-ALPHA, 4-BETA)-(+)-5-CYCLOHEXANE- 1-H-3, 2,3, 4-H-3 -TETROL - (H-3 CONDURITOL-B EPOXIDE)
GAL, AE
VOORSTAD, JP
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1987, 24 (04): : 397 - 407
[28] THE CHEMISTRY OF 5-BETA,6-BETA-EPOXY-4,4-DIMETHYLCHOLEST-1-EN-3-ONE - APPROACHES TO THE SYNTHESIS OF 1-ALPHA,5-ALPHA-CYCLOSTEROIDS .2.
GEORGHIOU, PE
REN, Y
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1993, 71 (03): : 364 - 370
[29] Development of selective inhibitors for the treatment of rheumatoid arthritis: (R)-3-(3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor
Chough, Chieyeon
Joung, Misuk
Lee, Sunmin
Lee, Jaemin
Kim, Jong Hoon
Kim, B. Moon
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1495 - 1510
[30] PREPARATION AND ODOR EVALUATION OF BOTH ENANTIOMERS OF 3,4,4A-ALPHA,5,6,7,8,8A-BETA-OCTAHYDRO-5,5,8A-BETA-TRIMETHYL-2(1H)-NAPHTHALENONE AND 1,2-ALPHA,3,4,4A-ALPHA,5,6,7,8,8A-BETA-DECAHYDRO-5,5,8A-BETA-TRIMETHYL-2-BETA-NAPHTHALENYL ACETATE, 4 WOODY ODORANTS
GAUTIER, A
VIAL, C
MOREL, C
LANDER, M
NAF, F
HELVETICA CHIMICA ACTA, 1987, 70 (08) : 2039 - 2044

← 1 2 3 4 5 →